Z. Dunbar

Update on the current revolution in cancer immunotherapy.

A. Shanker, Ariana N. Renrick, Z. Dunbar, 2019, Immunotherapy.

Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRASmut/P53mut Lung Cancer Cells by Inhibiting c-FLIP

E. Wijeratne, S. Dhandayuthapani, T. Kanagasabai, 2024, Cancers.